FDA Advisory panel to hold hearing on Johnson & Johnson vaccine
FDA Advisory panel to hold hearing on Johnson & Johnson vaccine

The FDA is expected to grant Johnson & Johnson emergency-use authorization for its COVID-19 vaccine as early as Friday night.